Molnunat 200mg

Molnunat 200mg capsules (Molnupiravir) used for the treatment of adult patients with COVID-19, who have high risk of progression of the disease including hospitalization or death

Molnunat 200mg (Molnupiravir) is a medication that works by introducing errors into the SARS-CoV- 2 virus' genetic code, which prevents the virus from further replicating. Molnupiravir is administered as four 200 milligram capsules taken orally every 12 hours for five days, for a total of 40 capsules. Molnupiravir is not authorized for use for longer than five consecutive days.